news Archives - Page 33 of 100 - Journal for Clinical Studies

Current Edition

Asia Pacific

Despite recent setbacks, the ophthalmology market still offers vast potential, says GlobalData

Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the mark...

Continue Reading →

news

A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple sclerosis than other existing therapies.

Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is a chronic neurodegener...

7 February 2019 news | North America | Regional News

Continue Reading →

news

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Breakthroug...

7 February 2019 news | North America | Regional News

Continue Reading →

news

FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exc...

7 February 2019 news | North America | Regional News

Continue Reading →

Europe

MacroGenics breast cancer drug tops Herceptin in late-stage trial

Results from a late-stage study showed MacroGenics' experimental drug margetuximab extended progression-free survival in previously treated HER-2 positive metastatic...

7 February 2019 Europe | news | Regional News

Continue Reading →

Europe

CHMP recommends approval of Praluent® (alirocumab) to reduce cardiovascular risk in people with established atherosclerotic cardiovascular disease

PARIS and TARRYTOWN, NY - February 4, 2019 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for...

7 February 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Weak Q4 results and MS portfolio should be cause for concern for Biogen, says GlobalData

Following Biogen’s Q4 and full year 2018 earnings call (29 January), Antoine Grey, Pharma Analyst at GlobalData, a leading data and analytics company, offers his vie...

7 February 2019 Europe | news | Regional News

Continue Reading →

Europe

New report calls for NHS workforce culture to be measured and reported to the CQC and NHS Improvement

Culture unmasked at the best and worst performing NHS hospital trusts Tuesday 5th February: A new report published today by Pulse UK, finds stark trends in the...

7 February 2019 Europe | news | Regional News

Continue Reading →

Europe

Isatuximab Phase 3 trial meets primary endpoint of prolonging progression free survival in patients with relapsed/refractory multiple myeloma

Study evaluated the benefit of isatuximab in combination with standard of care in prolonging progression free survival as compared to standard of care in patients wi...

7 February 2019 Europe | news | Regional News

Continue Reading →

Europe

Audion Therapeutics and REGAIN Consortium Announce Positive Phase I Results in Patients with Sensorineural Hearing Loss

AMSTERDAM, The Netherlands, February 05, 2019 / B3C newswire / -- The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the development of the...

7 February 2019 Europe | news | Regional News

Continue Reading →